← Back to Patent Explorer
US4543379A Expired / Lapsed US ⏱️ 0.0 years remaining

Soft and firm denture liner for a composite denture and method for fabricating

Assignee: Gulf South Research Institute
•
Filing: 1983-12-08
•
Granted: 1985-09-24
•
Expires: 2003-12-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention provides a denture liner composition for a composite denture based on a phosphonitrilic fluoroelastomer (poly(fluoroalkoxy)phosphazene) curable at atmospheric pressure at temperatures of 100° C. or less, conveniently by immersing the packed denture flask in a water bath at the appropriate temperature. The composition includes filler materials for increasing the hardness of the cured liner, interpenetrating polymers for increasing firmness and bond strength, and cross-linking agents for increasing the tensile strength and bond strength of the cured liner. The composite denture is preferably prepared in a one-step process wherein the liner composition material of a single firmness is cured in situ with the denture base material. Alternatively, a firm liner material may be cured at the periphery of the denture and a softer liner material cured at the center, in order to provide a firm elastic liner where adjustments must be made by grinding and where the patient's soft tissues must be displaced, and a soft elastic liner over the bony anatomy of the patient where stresses from chewing are most concentrated and the soft tissues are thin.

Inventors

  • 👤 Lawrence Gettleman
  • 👤 Charles L. Farris
  • 👤 H. Ralph Rawls
  • 👤 Ralph J. LeBouef, Jr.

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 18:00
CPC Classifications
C; C08; C08F; C08F283/00; A; A61; A61K; A61K6/00; A61K6/80; A61K6/884

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 34 words
A denture liner curable in situ with a denture base material comprising a phosphonitrilic fluoroelastomer, a C 1 -C 6 alkyl methacrylate monomer, and a cross-linking agent comprising a glycol ester of dimethacrylic acid.
Claim 2
Dependent Claim 34 words
A denture liner curable in situ with a denture base material comprising a phosphonitrilic fluoroelastomer, a C 1 -C 6 alkyl methacrylate monomer, and a cross-linking agent comprising a glycol ester of dimethacrylic acid.
Claim 3
Dependent Claim 62 words
The liner of claim 1 wherein the fluoroelastomer is present in an amount of from about 30% to about 98% by weight of the total composition, the monomer is present in an amount of from about 1% to about 40% by weight of the total composition, and the cross-linkng agent is present in an amount of from about 1 to about 12.5%.
Claim 4
Dependent Claim 37 words
The denture liner of claim 2, wherein the fluoroelastomer is characterized by a plurality of repeating units of the general formula ##STR3## wherein n is 3, 5, 7, 9, or 11 and m is 10,000 to 50,000.
Claim 5
Dependent Claim 34 words
The liner of claim 2 further including a free-radical initiator comprising lauroyl peroxide or benzoyl peroxide and an acid scavenger comprising MgO, wherein the composition is curable under atmospheric conditions at about 100° C.
Claim 6
Dependent Claim 13 words
The liner of claim 1 wherein the cross-linking agent is ethylene glycol dimethacrylate.
Claim 7
Dependent Claim 21 words
The liner of claim 1 further including a filler in an amount up to about 30% by weight of the composition.
Claim 8
Dependent Claim 20 words
The liner of claim 6, wherein the filler comprises particles of a hard acrylic resin, fumed silica, or barium sulfate.
Claim 9
Dependent Claim 15 words
A liner of claim 7, wherein the filler comprises particles of a poly(methyl methacrylate) resin.
Claim 10
Dependent Claim 75 words
The liner of claim 8 wherein the fluoroelastomer is present in an amount of from about 30% to about 98%, the filler is present in an amount of from about 7% to about 30%, the cross-linking agent is present in an amount of from about 1% to about 12.5%, and the monomer is present in an amount of from about 1% to 40%, wherein all amounts are expressed in percent by weight of the composition.

References Cited (Backward Citations)

US3702833A Cited
US3888799A Cited
US3945966A Cited
US4251215A Cited
US4433958A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-09-23 1989-03-25 1989-09-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-09-23 1993-03-25 1993-09-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-09-23 1997-03-25 1997-09-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag